Literature DB >> 26830284

Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV Infection.

Kristine M Erlandson1, Jordan E Lake2.   

Abstract

More than one-third of adults in the USA are obese and obesity-related disease accounts for some of the leading causes of preventable death. Mid-life obesity may be a strong predictor of physical function impairment later in life regardless of body mass index (BMI) in older age, highlighting the benefits of obesity prevention on health throughout the lifespan. Adipose tissue disturbances including lipodystrophy and obesity are prevalent in the setting of treated and untreated HIV infection. This article will review current knowledge on fat disturbances in HIV-infected persons, including therapeutic options and future directions.

Entities:  

Keywords:  Adipose tissue; Antiretroviral therapy; BMI; HIV; HIV infection; HIV/AIDS; Inflammation; Lipodystrophy; Obesity; Obesity and HIV; Review

Mesh：

Substances：

Year:  2016        PMID： 26830284      PMCID： PMC4779424          DOI： 10.1007/s11904-016-0298-8

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  143 in total

1.  Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy.

Authors:  Claude Béténé A Dooko; Stephane De Wit; Jacqueline Neuhaus; Adrian Palfreeman; Rosalie Pepe; James S Pankow; James D Neaton
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

2.  Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection.

Authors:  Leslie A Lenert; Martin Feddersen; Ann Sturley; Daniel Lee
Journal:  Am J Med       Date:  2002-08-15       Impact factor: 4.965

Review 3.  Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk.

Authors:  E Angela Murphy; Kandy T Velazquez; Kyle M Herbert
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-09       Impact factor: 4.294

4.  The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults.

Authors:  Robert Burgoyne; Evan Collins; Cheryl Wagner; Susan Abbey; Mark Halman; Margaret Nur; Sharon Walmsley
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

5.  Weight change after antiretroviral therapy and mortality.

Authors:  Bianca Yuh; Janet Tate; Adeel A Butt; Kristina Crothers; Matthew Freiberg; David Leaf; Mary Logeais; David Rimland; Maria C Rodriguez-Barradas; Christopher Ruser; Amy C Justice
Journal:  Clin Infect Dis       Date:  2015-03-11       Impact factor: 9.079

Review 6.  Possible beneficial role of exercise in modulating low-grade inflammation in the elderly.

Authors:  B K Pedersen; H Bruunsgaard
Journal:  Scand J Med Sci Sports       Date:  2003-02       Impact factor: 4.221

Review 7.  Lipodystrophy and quality of life of HIV-infected persons.

Authors:  Giovanni Guaraldi; Rita Murri; Gabriella Orlando; Nicola Squillace; Chiara Stentarelli; Stefano Zona; Elisa Garlassi; Esteban Martínez
Journal:  AIDS Rev       Date:  2008 Jul-Sep       Impact factor: 2.500

8.  Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

Authors:  Richard H Haubrich; Sharon A Riddler; A Gregory DiRienzo; Lauren Komarow; William G Powderly; Karin Klingman; Kevin W Garren; David L Butcher; James F Rooney; David W Haas; John W Mellors; Diane V Havlir
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

9.  TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages.

Authors:  Virginie Bourlier; Coralie Sengenès; Alexia Zakaroff-Girard; Pauline Decaunes; Brigitte Wdziekonski; Jean Galitzky; Phi Villageois; David Esteve; Patrick Chiotasso; Christian Dani; Anne Bouloumié
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

10.  Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study.

Authors:  Pere Domingo; María del Mar Gutierrez; José Miguel Gallego-Escuredo; Ferran Torres; Gracia María Mateo; Joan Villarroya; Ignacio de los Santos; Joan Carles Domingo; Francesc Villarroya; Luis Del Rio; Vicente Estrada; Marta Giralt
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240
View more
  25 in total

1.  Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.

Authors:  Takara L Stanley; Lindsay T Fourman; Meghan N Feldpausch; Julia Purdy; Isabel Zheng; Chelsea S Pan; Julia Aepfelbacher; Colleen Buckless; Andrew Tsao; Anela Kellogg; Karen Branch; Hang Lee; Chia-Ying Liu; Kathleen E Corey; Raymond T Chung; Martin Torriani; David E Kleiner; Colleen M Hadigan; Steven K Grinspoon
Journal:  Lancet HIV       Date:  2019-10-11       Impact factor: 12.767

2.  Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone.

Authors:  Netanya S Utay; Douglas W Kitch; Eunice Yeh; Carl J Fichtenbaum; Michael M Lederman; Jacob D Estes; Claire Deleage; Clara Magyar; Scott D Nelson; Karen L Klingman; Barbara Bastow; Amneris E Luque; Grace A McComsey; Daniel C Douek; Judith S Currier; Jordan E Lake
Journal:  J Infect Dis       Date:  2018-05-05       Impact factor: 5.226

Review 3.  Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function-Mechanisms and Possible Therapeutic or Preventive Measures: an Update.

Authors:  Ann A Verhaegen; Luc F Van Gaal
Journal:  Curr Obes Rep       Date:  2021-01-05

4.  Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy.

Authors:  Vanessa El Kamari; Carlee Moser; Corrilynn O Hileman; Judith S Currier; Todd T Brown; Liz Johnston; Peter W Hunt; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

Review 5.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

6.  CT Fat Density Accurately Reflects Histologic Fat Quality in Adults With HIV On and Off Antiretroviral Therapy.

Authors:  Jordan E Lake; Carlee Moser; Liz Johnston; Clara Magyar; Scott D Nelson; Kristine M Erlandson; Todd T Brown; Grace A McComsey
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 7.  Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

Authors:  Jennifer Totonchy; Ethel Cesarman
Journal:  Curr Opin Virol       Date:  2016-09-23       Impact factor: 7.090

Review 8.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

9.  Combined effects of HIV and obesity on the gastrointestinal microbiome of young men who have sex with men.

Authors:  R R Cook; J A Fulcher; N H Tobin; F Li; D Lee; C Woodward; M Javanbakht; R Brookmeyer; S Shoptaw; R Bolan; G M Aldrovandi; P M Gorbach
Journal:  HIV Med       Date:  2019-12-27       Impact factor: 3.180

10.  Associations between subcutaneous fat density and systemic inflammation differ by HIV serostatus and are independent of fat quantity.

Authors:  J E Lake; P Debroy; D Ng; K M Erlandson; L A Kingsley; F J Palella; M J Budoff; W S Post; T T Brown
Journal:  Eur J Endocrinol       Date:  2019-10       Impact factor: 6.664
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.